Top compounds associated with response to SLC2A13


Feature Type Standardized
Nominal ANOVA
mRNA simvastatin CTRPv2 pan-cancer AAC -0.093 0.02
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.08 0.02
mRNA AT-7519 GDSC1000 pan-cancer AAC -0.069 0.02
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.069 0.02
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.02
mRNA Axitinib CTRPv2 pan-cancer AAC 0.078 0.02
mRNA BRD-K19103580 CTRPv2 pan-cancer AAC -0.085 0.02
mRNA BIBW2992 CTRPv2 pan-cancer AAC -0.082 0.03
mRNA BRD-K20514654 CTRPv2 pan-cancer AAC 0.11 0.03
mRNA Vinorelbine GDSC1000 pan-cancer AAC -0.078 0.03
Download CSV